Last reviewed · How we verify
Extra-fine hydrofluoroalkane beclometasone dipropionate
Beclometasone dipropionate is a corticosteroid that works by reducing inflammation in the body.
Beclometasone dipropionate is a corticosteroid that works by reducing inflammation in the body. Used for Asthma, Chronic obstructive pulmonary disease (COPD).
At a glance
| Generic name | Extra-fine hydrofluoroalkane beclometasone dipropionate |
|---|---|
| Also known as | Qvar® |
| Sponsor | Research in Real-Life Ltd |
| Drug class | Corticosteroid |
| Target | Glucocorticoid receptor |
| Modality | Small molecule |
| Therapeutic area | Respiratory |
| Phase | Phase 2 |
Mechanism of action
It does this by binding to glucocorticoid receptors, which then decrease the production of inflammatory cytokines and other mediators of inflammation. This leads to a decrease in the symptoms associated with inflammation, such as swelling, redness, and pain.
Approved indications
- Asthma
- Chronic obstructive pulmonary disease (COPD)
Common side effects
- Oral thrush
- Headache
- Cough
Key clinical trials
- Does Extra-fine Hydrofluoroalkane-beclomethasone Dipropionate (HFA-BDP) Suppress Small Airways Inflammation in Chronic Obstructive Pulmonary Disease (COPD)? (PHASE4)
- Real-world Effectiveness and Cost-effectiveness of Qvar Versus FP, a US Study
- Qvar vs FP in Pediatrics
- Real-world Effectiveness and Cost-effectiveness of Leading Inhaled Corticosteroids in Asthma Management
- Qvar Therapy in Smoking Asthmatics
- Qvar Versus Clenil, a General Practice Research Database Study
- Real-world Effectiveness and Cost-effectiveness of HFA-beclometasone Compared With ICS/LABA Combination Therapy
- Real-life Effectiveness and Cost-effectiveness of Qvar Versus FP and BDP in the Management of COPD
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: